☆ 4.7 Letter

Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study

LEUKEMIA (2009)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 23, Issue 2, Pages 402-404

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2008.185

Keywords

-

Categories

Oncology Hematology

Funding

  1. NCI NIH HHS [P30 CA021765-30, CA-21765, P30 CA021765] Funding Source: Medline
  2. NIGMS NIH HHS [U01GM61374, U01 GM061374-07, U01 GM061374, U01 GM61393, U01 GM061393, U01 GM061393-09] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.